Gabelli & Co Investment Advisers’s Vigil Neuroscience VIGL Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio VIGL Stock Details VIGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-864,950	Closed	-$6.88M	–	329
2025 Q2	$6.88M	Buy	+864,950	New	+$3.88M	1.06%	25

Other funds holding VIGL

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Gabelli & Co Investment Advisers's VIGL Position: Q3 2025 in Review

Gabelli & Co Investment Advisers sold out of Vigil Neuroscience (VIGL) in Q3 2025, closing a stake of 864,950 shares — an estimated $6.88M sold.

Gabelli & Co Investment Advisers first reported a position in VIGL in Q2 2025 and held it in 1 quarter. The position peaked at $6.88M in Q2 2025. 2 funds tracked by Wall St. Rank hold VIGL as of Q3 2025.

Gabelli & Co Investment Advisers reported no remaining Vigil Neuroscience position as of Q3 2025 after selling out during the quarter.
Gabelli & Co Investment Advisers sold 864,950 Vigil Neuroscience shares in Q3 2025, an estimated $6.88M.
Gabelli & Co Investment Advisers first reported a position in Vigil Neuroscience in Q2 2025 and held it in 1 quarter.
Gabelli & Co Investment Advisers's Vigil Neuroscience position peaked at $6.88M in Q2 2025.
2 funds tracked by Wall St. Rank held Vigil Neuroscience as of Q3 2025.

Based on Gabelli & Co Investment Advisers's 13F filing for Q3 2025, filed 12 Nov 2025.